Decibel Therapeutics IPO

Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine.

Total Funding to Date$132.06MM
Register for Details

For more details on financing and valuation for Decibel Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Decibel Therapeutics Ticker Symbol


Decibel Therapeutics Stock Price

$3.13 as of 12/2/22